CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength
The Health Care sector underperformed in 2023, but defensive Health Care equities are now performing well amid a tone shift on Wall Street. CVS Health appears undervalued and has positive technical...
CVS sees 2024 Medicare Advantage enrollment beating expectations
CVS Health Corp. CVS, -0.46% said Friday that its 2024 Medicare Advantage enrollment is beating expectations, with membership set to grow by at least 800,000. During the annual enrollment period fo...
CVS says 2024 Medicare Advantage enrollment exceeds expectations
CVS Health said on Friday enrollment for 2024 in some of its Medicare Advantage plans, through which it provides health insurance for people aged 65 and older, exceeded its expectations.
CVS names interim CFO Tom Cowhey as permanent finance chief
CVS Health Corp. CVS, -0.46% said Friday it has appointed Tom Cowhey, currently senior vice president of corporate finance and interim chief financial officer as its permanent CFO. The drug store c...
Here's Why CVS Health (CVS) Fell More Than Broader Market
CVS Health (CVS) closed the most recent trading day at $80.51, moving -0.46% from the previous trading session.
CVS Pharmacy Launches Simplified, Two-Tiered Loyalty Program
CVS Pharmacy, the retail division of CVS Health, simplified its loyalty program by consolidating it into one membership with two tiers. With both tiers of the ExtraCare program, CVS Pharmacy will o...
CVS Partially Dropping Top-Selling Drug Humira In Favor Of Cheaper Biosimilars
CVS Caremark, the pharmaceutical subsidiary of CVS Health, announced Wednesday it will replace AbbVie's Humira from its list of covered drugs with cheaper alternatives for some customers—a move tha...
CVS Health stock a top broker pick; faster earnings growth seen
CVS Health Corp (NYSE:CVS) has two things it didn't have during the past few years: a clear path to accelerating earnings growth; and appropriately reset expectations, according to Bank of America ...
CVS Health (CVS) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, CVS Health (CVS) stood at $78.62, denoting a +1.79% change from the preceding trading day.
Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts oft...
CVS Health (CVS) New Opportunities Drive Growth, Macro Woes Stay
CVS Health's (CVS) restructuring plan poises it well, along with its strategic buyouts.
Top Wall Street analysts favor these 3 dividend stocks for the long haul
TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including CVS Health and Devon Energy.
Can CVS's Transparent Drug Pricing Cure An Industry Epidemic?
CVS's store receipts may stay long, but its prescription slips are about to get shorter.
Fmr. FDA Commissioner Dr. Scott Gottlieb on FDA approval of CRISPR treatment, CVS' new drug model
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss FDA's approval of the country's first gene-editing treatment for patients with stickle cell disease, where the greatest oppo...
The Score: Spotify Technology, CVS Health, Alphabet and More Stocks That Defined the Week
Here are some of the major companies whose stocks moved on the week's news.
Related Companies